The Impact of Motivational Interviews Conducted Through Tele-Nursing on Diabetes Management
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Jan 6, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study will be conducted with a single-center, single-blind, parallel-group, randomized controlled design with a follow-up period of 6 months.The population of the study consists of 141 adolescents aged 13-18 diagnosed with Type 1 diabetes, who are being followed up at the Diabetes Education Unit of Evliya Çelebi Training and Research Hospital, affiliated with Kütahya Health Sciences University in the province of Kütahya, Türkiye. The sample of the study will consist of 96 adolescents, with 48 participants in each group, assuming a 1:1 randomization, based on the reference study. In thei...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Type 1 diabetes at least 6 months ago
- • Under follow-up at Kütahya Evliya Çelebi Health Sciences University Training and Research Hospital Diabetes Education Unit
- • Having an HbA1c level above 7.5% in the most recent measurement
- • Having a smartphone
- Exclusion Criteria:
- • Refusal of legal guardian or the adolescent themselves to participate in the research
- • Difficulty in communication or answering questions
- • Having hearing, speech, vision, or cognitive impairments
- • Being in the honeymoon period of Type 1 diabetes
- • Having a second autoimmune disease, such as celiac disease, besides Type 1 diabetes
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eskişehir, Odunpazarı, Turkey
Eskişehir, , Turkey
Patients applied
Trial Officials
Pınar Duru, Ph.D.
Principal Investigator
Eskisehir Osmangazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported